CY, Y., HS, L., YB, J., SK, C., CB, C., YK, S., . . . SY, B. (2024). Transcriptomic network analysis reveals key drivers of response to anti-TNF biologics in patients with rheumatoid arthritis. Rheumatology (Oxford, England), 63(5), 1422. https://doi.org/10.1093/rheumatology/kead403
Chicago Style (17th ed.) CitationCY, Yu, et al. "Transcriptomic Network Analysis Reveals Key Drivers of Response to Anti-TNF Biologics in Patients with Rheumatoid Arthritis." Rheumatology (Oxford, England) 63, no. 5 (2024): 1422. https://doi.org/10.1093/rheumatology/kead403.
MLA (9th ed.) CitationCY, Yu, et al. "Transcriptomic Network Analysis Reveals Key Drivers of Response to Anti-TNF Biologics in Patients with Rheumatoid Arthritis." Rheumatology (Oxford, England), vol. 63, no. 5, 2024, p. 1422, https://doi.org/10.1093/rheumatology/kead403.